Hyland Catherine

Image of Catherine Hayland

Prof Catherine Hyland

Principal Research Fellow

Professor, Queensland University of Technology (QUT)

Connect with Prof Hyland Email Pubmed

Among other things, Catherine’s interested in the ways we can learn more about babies’ blood types before they're born, such as their RhD blood group and other atypical blood group antigens. The techniques include cell-free DNA and non-invasive prenatal assessments. These studies have been part of an exciting clinical, academic and industry collaborative research with translational outcomes for transfusion medicine.

Catherine was awarded a PhD from the University of Queensland for studies characterising the molecular diversity of the Rh (Rhesus) blood group system.

Outside Australia, Catherine has worked on immunogenetic training and experience in the University Hospital in Leiden, the Netherlands, and at the University of California, San Diego. She’s published consistently in peer review journals, and presents annually at international and national professional meetings.

  • ISBT Working Party for Red Cell Antigen Nomenclature and Terminology
  • Technical Working Party for Standards Australia
  • Australian and New Zealand Society of Blood Transfusion (ANZSBT)

Key publications

Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation
Hyland CA, O'Brien H, Flower RL, Gardener GJ
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
Targeted exome sequencing designed for blood group, platelet, and neutrophil antigen investigations: Proof-of-principle study for a customized single-test system
Roulis E, Schoeman E, Hobbs M, Jones G, Burton M, Pahn G, Liew YW, Flower R, Hyland C
Comprehensive blood group antigen profile predictions for Western Desert Indigenous Australians from whole exome sequence data
Schoeman EM, Roulis EV, Perry MA, Flower RL, Hyland CA
Developments beyond blood group serology in the genomics era
Hyland CA, Roulis EV, Schoeman EM
Br J Haematol.
Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory setting
Schoeman EM, Roulis EV, Liew YW, Martin JR, Powley T, Wilson B, Millard GM, McGowan EC, Lopez GH, O'Brien H, Condon JA, Flower RL, Hyland CA